Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age
The incidence of neuroendocrine neoplasia (NEN) is higher in individuals ≥70 years of age (elderly) who are underrepresented in clinical trials because of comorbidities and low performance status. We retrospectively analyzed the outcome of elderly patients with metastatic NEN (mNEN). Comorbidities w...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Bioscientifica
2018-12-01
|
| Ráidu: | Endocrine Connections |
| Fáttát: | |
| Liŋkkat: | https://ec.bioscientifica.com/view/journals/ec/7/12/EC-18-0478.xml |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|